These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes. Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus. Biesecker G; Lavin L; Ziskind M; Koffler D N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697 [TBL] [Abstract][Full Text] [Related]
9. [Solubility of immune complexes and activity of the alternative complement pathway in patients with systemic lupus erythematosus]. Riera Cervantes N; Geffner J; Isturiz MA; Manni JA; de Bracco MM Rev Clin Esp; 1985 Oct; 177(6):254-7. PubMed ID: 4081196 [No Abstract] [Full Text] [Related]
10. C3 receptors, complement deficiency and SLE. Walport M; Lachmann P Br J Rheumatol; 1984 Feb; 23(1):3-5. PubMed ID: 6697070 [No Abstract] [Full Text] [Related]
19. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus. Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233 [TBL] [Abstract][Full Text] [Related]
20. The role of complement in the aetiopathogenesis of systemic lupus erythematosus. Gatenby PA Autoimmunity; 1991; 11(1):61-6. PubMed ID: 1839881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]